Sarah Low
7Patents
2h-index
25Co-inventors
43Inventor score
Filing activity: Jul 21, 2016 → Oct 20, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10793634B2 | Anti-TrkB antibodies | Chemistry; Metallurgy | 2 | Active |
| US10280231B2 | Compound targeting IL-23A and B-cell activating factor (BAFF) and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US12110335B2 | Bispecific anti-VEGF and anti-TrkB binding molecules for the treatment of eye diseases | Chemistry; Metallurgy | 0 | Active |
| US10844138B2 | Compound targeting IL-23A and B-cell activating factor (BAFF) and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11866501B2 | Anti-TrkB antibodies | Chemistry; Metallurgy | 0 | Active |
| US11884744B2 | Compound targeting IL-23A and B-cell activating factor (BAFF) and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11661458B2 | Anti-NRP1A antibodies and their uses for treating eye or ocular diseases | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.